Growing evidence suggests important roles for specialized platelet-derived growth factor receptor alpha-positive (PDGFRalpha + ) cells in regulating the behaviors of visceral smooth muscle organs. Examination of the female reproductive tracts of mice and monkeys showed that PDGFRalpha + cells form extensive networks in ovary, oviduct, and uterus. PDGFRalpha + cells were located in discrete locations within these organs, and their distribution and density were similar in rodents and primates. PDGFRalpha + cells were distinct from smooth muscle cells and interstitial cells of Cajal (ICC). This was demonstrated with immunohistochemical techniques and by performing molecular expression studies on PDGFRalpha +
INTRODUCTION
The organs of the female reproductive tract provide a diverse array of biological functions, including: 1) growth and maturation of oocytes in the ovary [1] [2] [3] , 2) transport of mature eggs along the oviduct to the site of fertilization, 3) transport of fertilized embryos through the terminal regions of the duct and into the uterus for implantation [4, 5] , 4) development of the fetus within the protective environment of the uterus [6] , and 5) expulsion of the fetus through the birth canal [7] [8] [9] . Such complicated movements require the coordinated activity of many types of cells, including several types of smooth muscle cells (SMCs), intramural neurons, and specialized interstitial cells providing pacemaker activity (interstitial cells of Cajal [ICCs]) [10] .
A population of interstitial cells in the gastrointestinal (GI) tract, known traditionally as fibroblast-like cells [11] , has recently been shown to be labeled selectively with antibodies against platelet-derived growth factor receptor a (PDGFRa) [12] [13] [14] . Interstitial cells immunopositive for PDGFRa have also been discovered in the muscularis of the bladder [15] [16] [17] . PDGFRa þ cells are distinct from nerve elements, ICCs, and SMCs [12] [13] [14] . PDGFRa þ cells form close associations with nerve fibers, express signal transduction and effector molecules appropriate for receiving and translating neural inputs, and form gap junctions with SMCs. Evidence has developed that PPDGFRa þ cells in the GI tract and bladder mediate inhibitory neurotransmission in these organs. A second population of PDGFRa þ cells was also found within the mucosa tissue of mouse and human GI organs [18] . These cells line the epithelium and are closely associated with the basolateral surface of epithelial cells. In the bladder, PDGFRa þ cells are located in the suburothelium and in the lamina propria of the mucosa [15, 17] .
In the present study we have examined the distribution of PDGFRa þ cells in the mouse and monkey ovary, oviduct, and uterus (endometrium and myometrium). We have found that this class of interstitial cells is extensively distributed throughout the female reproductive tract. Double-labeling immunohistochemistry shows that PDGFRa þ cells are distinct from SMCs. We also used transgenic mice engineered to express an enhanced green fluorescent protein (eGFP)-histone 2B fusion protein driven off of the endogenous promoter for Pdgfra [19] . With these mice we were able to unequivocally identify PDGFRa þ cells in the mixed cell population after enzymatic dispersion of tissues, sort cells by fluorescenceactivated cell sorting (FACS), and perform molecular expression studies to characterize prominent gene expression profiles in order to begin selective phenotyping. We found marked differences in gene expression in PDGFRa þ cells from the ovary, oviduct, and uterus. This population of cells also showed expression differences within the same organ (e.g., uterine myometrium vs. endometrium). The extensive distribution and differential gene expression profiles of PDGFRa þ 1 Supported by National Institutes of Health (NIH) grants R01 DK-57326 to S.M.W., R01 DK-091336 to K.M.S. and S.M.W., and GM103554 to T.W.G. Morphological and molecular studies were performed in a Core laboratory supported by NIH grant P01 DK41315. Confocal images were collected using a Zeiss LSM510 Meta confocal microscope obtained with support from the grant NIH1 S10 RR16871. FACS was performed with support from NIH COBRE P30GM110767. 2 Correspondence: E-mail: smward@medicine.nevada.edu. 3 These authors contributed equally to this work and should be considered co-first authors.
cells throughout the female reproductive tract suggest this population of interstitial cells has multiple and region-specific physiological roles.
MATERIALS AND METHODS

Animals
Female Pdgfra tm11 (EGFP)Sor /J and C57BL/6 mice were obtained from The Jackson Laboratory. Mice were exposed to isoflurane (AErrane; Baxter) inhalation, immediately followed by cervical dislocation. An incision was made in the abdominal wall, and the ovaries, oviducts, and uterine horns were removed and placed in Krebs-Ringer buffer (mmol L À1 ): NaCl, 118.5; KCl, 4.5; MgCl 2 , 1.2; NaHCO 3 , 23.8; KH 2 PO 4 , 1.2; dextrose, 11.0; and CaCl 2 , 2.4, at 48C for further preparation. Reproductive tissues were collected from mice during the proestrus stage of the estrus cycle, which was determined by cytological analysis of vaginal smears. The Institutional Animal Care and Use Committee at the University of Nevada, Reno approved all procedures used. The female reproductive tracts from cynomolgus monkeys between the ages of 2 and 8 yr were obtained from Charles River Laboratories and used for the studies described. Tissues were transported in precooled Krebs-Ringer buffer to the University of Nevada, Reno and fixed within 2 h after animals were killed. All animals were maintained and experiments performed in accordance with the National Institutes of Health Guide for the Care and Use of Laboratory Animals.
Immunohistochemistry
Mouse female reproductive tracts were pinned to the base of a Sylgard elastomer-lined (Dow Corning), and ovaries and oviducts were isolated from uterine horns by sharp dissection. Oviducts were uncoiled by microdissection from the ''proper ligament'' and pinned to the Sylgard base so that the ampullato-isthmus orientation was retained for future identification. In nonhuman primate (NHP) tissues, ovaries and oviducts were separated from uterus as described above. Tissues were fixed in paraformaldehyde (4% w/v in 0.1 M PBS for 15 min at 48C) or acetone (10 min at 48C) for mouse tissues, or 1 h (paraformaldehyde) and 30 min (acetone) for monkey. Following fixation, some oviducts were separated into ampulla and isthmus segments for transverse sections, whereas others were kept intact for longitudinal-orientated sections. All tissues were washed for 24 h in PBS (0.01 M, pH 7.2). For cryostat sections tissues were dehydrated in graded sucrose solutions (5%, 10%, 15%, and 20% w/v in PBS; 15 min each for 5%, 10%, and 15%, and overnight in 20%), embedded in a 1:1 mixture of 20% sucrose in PBS and Tissue Tek (Miles), and rapidly frozen in liquid nitrogen-cooled 2-methylbutane. Cryostat sections (10 lm) were cut (Leica CM3050 cryostat) and collected on Vectabond-coated slides (Vector Labs Inc.). Sections were washed in PBS (4 3 15 min) and incubated with bovine serum albumin (1% w/v; Sigma Chemical Co.) for 1 h at room temperature. Primary and secondary antibody combinations and concentrations used are listed in Table 1 . Immunoreactivity was detected using the appropriate Alexa Fluor 488 or 594 secondary antibodies (Life Technologies). Before mounting, tissue sections were washed overnight in 0.01 M PBS to remove excess secondary antibody. Control experiments were performed in the absence of primary or secondary antibodies. Mounted specimens were examined using a Zeiss LSM 510 Meta confocal microscope (Carl Zeiss). Confocal micrographs are digital composites of Z-series scans of 1-lm optical sections. Final 1-lm images were constructed, and montages were assembled using a Zeiss LSM 5 Image Examiner and converted to Tiff files for final processing in Adobe Photoshop CS5 software (Adobe Co.) and Photoshop 7.0 and Corel Draw 7.0 (Corel Corp.).
Tissue Dispersion and Cell Purification
Mouse ovaries, oviducts, and uterine horns were equilibrated in Ca 2þ -free Hanks solution, tissues were dissected into 1 mm 3 , and cells were enzymatically dispersed as described previously [20] . Following enzymatic dispersion cells were immediately suspended in Hanks solution at 48C to minimize gene transcript changes. The eGFP þ -PDGFRa cells were purified by FACS (Becton Dickinson FACSAriaII) using the blue laser (488 nm) and eGFP emission detector (530/30 nm). Expression of genes in PDGFRa þ cells was compared against expression in the total cell population from each organ. Total cell population represents all cells dispersed from each organ (eGFP þ and eGFP À ).
RNA Isolation and Quantitative RT-PCR
Total RNA was isolated from PDGFRa þ cells from ovaries, oviducts, and uterus using an illustra RNAspin Mini RNA Isolation kit (GE Healthcare). Concentration and purity of RNA were measured using an ND-1000 Nanodrop Spectrophotometer (Nanodrop). Total RNA was reverse transcribed with qScript cDNA SuperMix (Quanta Biosciences) in a 53 reaction buffer containing optimized concentrations of MgCl 2 , deoxynucleoside triphosphates (deoxyadenosine triphosphate, deoxycytidine triphosphate, deoxyguanosine triphosphate, and deoxythymidine triphosphate), recombinant RNase inhibitor Primer name Primer sequence Accession no.
Gapdh-F
protein, qScript reverse transcriptase, random primers, oligo (dT) primer, and stabilizers, followed by heat inactivation. Polymerase chain reaction was performed with specific primers ( 
RESULTS
Enhanced GFP PDGFRa þ Cells Within the Mouse Female Reproductive Tract
The distribution of PDGFRa þ cells in the murine female reproductive tract was examined using Pdgfra tm11 (EGFP)Sor /J mice. Because eGFP is expressed in these mice as a fusion protein with histone 2B, it is limited to cell nuclei [19] . Therefore, we used fluorescence in combination with differential interference contrast (DIC) microscopy to identify the structures of the different reproductive organs and reveal the distribution of PDGFRa þ cells. We also verified that cells expressing eGFP were PDGFRa þ cells by double labeling of cells with PDGFRa antibodies (see below).
In the ovaries, PDGFRa þ cells were distributed within the theca externa and interna ( Fig. 1, A-F) . PDGFRa þ cells surrounded follicles (Fig. 1, B and E). Granulosa cells were also PDGFRa þ ( Fig. 1 , E and F). At higher magnification, the ovarian surface epithelium surrounding the ovaries was also found to contain PDGFRa þ cells (Fig. 1 , A-F). The distribution of PDGFRa þ cells in oviducts depended on the region of the oviduct. In the ampulla, PDGFRa þ cells were found within the myosalpinx and endosalpinx. In the mucosa, PDGFRa þ cells were located in folds deep into the lumen of the duct (Fig. 1, G-I ). In the isthmus, PDGFRa þ cells were located in the thicker myosalpinx and also in the epithelium (Fig. 1 , J-L). Because the mucosal folds are not as prominent in the isthmus as in the ampulla, PDGFRa þ cells were not as numerous in this location. In the uterine horn, eGFP þ nuclei were densely distributed throughout the myometrium and within the stroma of the endometrium (Fig. 1, M 
-O).
The cytoplasmic processes and general morphology of PDGFRa þ cells were investigated by secondary labeling of cells expressing eGFP with antibodies against PDGFRa. Immunolabeling of cells in the ovaries of mice identified an extensive network of PDGFRa þ cells (Fig. 2) . PDGFRa immunoreactivity was broadly distributed within the stroma, theca interna and externa, and ovarian epithelium (Fig. 2 , A-F). Enhanced GFP þ nuclei were located within cells immunopositive for PDGFRa. The processes of the PDGFRa þ cells were intertwined with adjacent PDGFRa þ cells, making it difficult to identify individual cellular structures (Fig. 2 , G-I).
PDGFRa þ cells were distributed along the outer periphery of oviducts and within the myosalpinx (Fig. 3 , A-I). A dense distribution of PDGFRa þ cells was also observed along the inner aspect representing the mucosal epithelium (Fig. 3 , A-F and J-L). In the ampulla region, PDGFRa þ cells were detected deep within the endosalpinx folds, whereas in the isthmus region the cells were distributed within the epithelial stroma along the inner aspect of the myosalpinx (Fig. 3, D-I ).
In the uterus, PDGFRa þ cells formed a dense network in the endometrial stroma that extended from the myometrial edge to the innermost epithelial lining (Fig. 4) . PDGFRa þ cells were also extensively distributed within the myometrium, where they formed a network from the inner endometrial/myometrial surface to the serosal edge (Fig. 4 , G-I).
Previously, studies have reported that some SMCs express PDGFRa, either during development or as a mature phenotype [21, 22] . We investigated whether PDGFRa þ cells are a cell type distinct from SMCs in the reproductive tract by performing double labeling with antibodies against PDGFRa and smooth muscle myosin II heavy chain (Smmhc), a specific marker for SMCs. In the ovary, PDGFRa þ cells were a distinct population of cells from SMCs (Fig. 5 , A-C). Smmhc þ cells were sandwiched between an inner and an outer layer of PDGFRa þ cells. A novel observation in these experiments was the presence of a very distinct SMC layer, several cells in thickness, surrounded by maturing follicles (Fig. 5 , A-C). In some sections there was an apparent thinning of the smooth muscle layer towards the outer edges of the larger follicles, suggesting the possible involvement of smooth muscle contraction and an asymmetric contractile force that could rupture at this thinner site during ovulation, allowing for the release of the egg (Fig. 5 , A-C) [23] [24] [25] .
Double labeling of the ampulla and isthmus of oviducts with antibodies against PDGFRa and Smmhc showed that PDGFRa þ cells are also distinct from SMCs along the length of the oviduct (Fig. 5, D-I ). In the ampulla, PDGFRa þ cells were located along the serosa of the ducts and were tightly interspersed with SMCs in the myosalpinx. PDGFRa þ cells extended deeper into the lamina propria of the endosalpinx than the Smmhc þ SMCs (Fig. 5, D-F) . In the isthmus, PDGFRa þ cells were present in similar locations as have been described for the ampulla region but were in higher density, likely because of the thicker muscle wall in this region of the duct (Fig. 5 , G-I). Double labeling also confirmed that the Pdgfra þ cells were not immunoreactive for the receptor tyrosine kinase Kit, ruling them out as ICCs in the oviduct (data not shown), as previously described [26] . In the uterus, PDGFRa þ cells were densely distributed in the endometrial stroma, which matched the distribution of eGFP þ nuclei in PDGFRa cells shown in Figure 1 , M-O (Fig.  4) . PDGFRa immunoreactivity was also observed in the myometrium. This labeling was restricted to the interstitial spaces between SMCs. As in other locations in the female reproductive tract, cellular colocalization of PDGFRa and Smmhc immunoreactivity was not observed (Fig. 5, J-L) . A thin layer of PDGFRa þ cells was also detected on the serosal aspect of the myometrium that matched the eGFP nuclear labeling in this region of the uterine wall (see Fig. 1 , M-O, and Organs from the female reproductive tract were also double labeled with antibodies against PDGFRa and vimentin because this is a common label used for the identification of interstitial cells in the GI tract [27] and bladder [15] , and Vim transcripts were expressed in Pdgfra þ cells (see below). Few PDGFRa þ cells displayed vimentin-like immunoreactivity in the female murine reproductive tract (Fig. 6 ).
PDGFRa þ Cells in the NHP Female Reproductive Tract
We also investigated the distribution and density of PDGFRa þ cells in the female reproductive tract of cymologous monkeys, a widely used primate model that shares approximately 93% DNA sequence homology with humans [28] . In NHP ovaries, PDGFRa þ cells were widely distributed within the theca externa and interna. The density was similar or The eGFP PDGFRa þ nuclei were densely distributed within the ovary stroma and the theca externa and interna. The eGFP PDGFRa þ nuclei were observed to surround follicles (A-C). Granulosa cells were PDGFRa þ (arrows). The ovarian epithelium also contained PDGFRa þ nuclei (A-F, asterisks). G-L) Distribution of eGFP PDGFRa þ nuclei within the oviduct. In the ampulla, eGFP PDGFRa þ nuclei were located within the myosalpinx (G-I, arrowheads) and were also found within the folds of the endosalpinx (G-I, arrows). In the isthmus region, eGFP PDGFRa þ nuclei were located within the thicker muscle wall (J-L, arrowheads) and also in the underlying epithelium (arrows). M-O) In the uterine horn, eGFP þ nuclei were densely distributed within the myometrium (arrowheads) and within the stroma of the endometrium (arrows). Bars indicated in C, F, I, L, and O correspond to their respective panels.
possibly greater than that observed in the mouse (Fig. 7) . Double labeling with PDGFRa þ cells and Smmhc revealed that these cells were immunonegative for Smmhc, suggesting that they were a population of cells distinct from SMCs (Fig.  7) . Similar to that observed in mouse, there were distinct layers of Smmhc þ SMCs that surrounded follicles and were found on the inner/outer layers of PDGFRa þ cells that also surrounded follicles, providing evidence that the presence of SMCs around follicles also occurs in primates.
In the NHP oviduct, PDGFRa þ cells also formed a distinct cellular phenotype from smooth muscle within the myosalpinx and epithelium (Fig. 8, A-F) . In the monkey uterus, PDGFRa þ cells were preferentially located within the interstitial spaces surrounding and between larger smooth muscle bundles. In the myometrium, PDGFRa þ cells were also found interposed between SMCs within muscle bundles (Fig. 8, G-L) , whereas in the endometrium PDGFRa þ cells were widely distributed in a dense meshwork but were distinct from SMCs that were predominantly located within blood vessels (Fig. 8, M-O) .
Nonhuman primate female reproductive tracts were also double labeled with antibodies against PDGFRa and vimentin. Except for the uterine endometrium, only occasional PDGFRa þ cells displayed vimentin-like immunoreactivity in the monkey female reproductive tract (Fig. 9 ).
These data suggest that vimentin is not a suitable label for the identification of these cells in the female reproductive tract. /J mice were readily identified in enzymatic dispersions of reproductive organs (Fig. 8, A-L) , making it possible to sort these cells by FACS using the fluorescence of eGFP located to the nuclei. We used these techniques to evaluate the expression of genes in the populations of PDGFRa þ cells isolated from the female reproductive tract and characterized genes encoding receptors and downstream signaling molecules expressed by these cells. Gene expression in PDGFRa þ cells were compared with total cell expression levels from the tissues where the cells originally resided. Sorting plots of the enriched populations of PDGFRa þ cells from ovary, oviduct, uterus myometrium, and endometrium are shown (Fig. 10, M-P) . Gates on each plot represent the PDGFRa þ cell population sorted for end point PCR and qPCR analyses.
Isolation and Molecular Characterization of PDGFRa
We characterized the phenotypes of PDGFRa þ cells from different organs using genes associated with distinct mesenchymal cell groups: 1) SMCs, 2) ICCs, 3) fibroblast-like cells, 
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þ CELLS IN THE FEMALE REPRODUCTIVE TRACT 4) myofibroblasts, and 5) mesenchymal stem cells. A secondary analysis was performed using genes indicative of cellular functions. We probed expression of genes involved in 1) housekeeping, 2) pacemaker activity, 3) hormone and neurotransmitter receptors, 4) signal transduction, and 5) proliferation, migration, and connectivity. In confirmation of cell purity, PDGFRa was expressed highly in cells from all organs sorted on eGFP compared with the total cell population ( Fig. 11 and Table 3 ). PDGFRa þ cells did not express a smooth muscle phenotype, because weaker expression of Myh11 was detected in PDGFRa þ cells from all organs except the ovary, compared with total cellular expression. These data support the immunohistochemical analysis that PDGFRa þ cells are a cellular population distinct from SMCs (Fig. 5) . It is unlikely that the PDGFRa þ cells represent a subpopulation of ICCs and are involved in pacemaker activity, because they expressed the prominent ICC gene Kit weaker than total cellular expression, and Ano1 (see below) was almost undetectable. These data were also consistent with the immunohistochemical findings that PDGFRa þ cells represent a population of cells distinct from ICCs. The fibroblast-like or myofibroblast phenotype in ovary PDGFRa þ cells was investigated by probing for Vimentin (Vim), Cd34, and Gja1 (encoding the gap junction alpha-1 protein or connexin 43). PDGFRa þ cells displayed enhanced Vim and Cd34 compared with the total cell population. However, it is unlikely Vim is translated, because of the lack of immunohistochemical detection or protein in these cells in the mouse reproductive PERI ET AL.
tract. Gja1 was more highly expressed in PDGFRa þ cells in oviduct and uterine myometrium and endometrium but was downregulated in ovary compared with total cellular expression. Cd34 and Cd44 were evaluated to identify possible mesenchymal stem cell gene expression in PDGFRa þ cells. Cd34 was more highly expressed in PDGFRa þ cells in all organs of the female reproductive tract in comparison with the total cell population, whereas Cd44 transcripts were enhanced in ovary PDGFRa þ cells, were not different in the oviduct, and were weaker in the uterus (Fig. 11 and Table 3 ).
An analysis of genes involved in cellular function revealed that Ano1-encoding a calcium-activated chloride conductance anoctamin-1, also known as Tmem16a, that is highly expressed in ICCs (see above) and is responsible for the generation of pacemaker activity in the GI tract [20, 29] -was present in oviduct and uterus but not resolved in the PDGFRa þ cells of these organs. The purine receptor P2ry1 was more highly expressed in PDGFRa þ throughout all organs of the female reproductive tract, as was Kcnn3, encoding the apaminsensitive small conductance calcium-activated potassium channel SK3 or K Ca 2.3. These two genes are highly expressed in PDGFRa þ cells in the GI tract and bladder, where they are involved in mediating and transducing purine neural or hormonal responses in these tissues. Finally, because of the high density of PDGFRa þ cells throughout the female reproductive tract, we evaluated these cells for expression of the early response transcription factor and proto-oncogene Fos. Fos was very highly expressed in PDGFRa þ cells in the ovary compared with total cellular expression, was expressed to a lesser degree in uterine myometrium, and was downregulated in the endometrium (Fig. 12 and Table 3 ). Regional differences in gene expression suggest different physiological functions for PDGFRa þ cells in different organs and in different regions of the same organ of the female reproductive tract (Table 3) .
DISCUSSION
In the present study we showed that Pdgfra tm11 (EGFP)Sor /J mice provide a powerful new model for studying PDGFRa Previously, expressions of PDGFs and PDGFRs in the rat and porcine ovaries have been investigated at different developmental stages and within the corpus luteum of sexually mature adults. The effects of PDGF ligands and receptors on luteogenesis in the rat were also examined [30, 31] . In the rat ovary, PDGF proteins (PdgfA, PdgfB, and PdgfC) were localized to the oocyte membrane or surrounding somatic PDGFRalpha þ CELLS IN THE FEMALE REPRODUCTIVE TRACT cells. PdgfAA was localized to oocyte and somatic cell clusters and within granulosa cells of follicles. PdgfB was localized to theca cells of secondary and antral follicles and was also apparent in the basement membrane between the granulosa and theca cell layers of secondary follicles. Prominent PdgfC labeling was present in cells of the theca layer of follicles [30] . PDGFRa þ cells were reported to be distributed in primordial follicles, localized to either the oocyte or pregranulosa cells in the rat [30] , and to theca cells and basal granulosa cells (weakly) in the pig [32] , whereas PDGFRb þ cells were localized to cells surrounding primordial and primary follicles and in the thecal cells of follicles of rat and pig [30, 33] . The present study expands these studies to include a description of the cells expressing PDGFRa in mouse and NHPs. Within the corpus luteum, PDGFRa þ cells were also localized to a population of luteal parenchymal cells, whereas PDGFRb expression was localized to the luteal microvasculature [31] . Intraovarian injection of tyrphostin AG1295, an inhibitor of Isthmus PDGFRa þ cells were present in similar locations as the ampulla but were more obvious in the myosalpinx because of the thicker muscle wall. Mucosal folds were reduced in the isthmus, and PDGFRa þ cells were typically not observed. J-L) In the uterus, PDGFRa þ cells (arrows) were densely distributed within the endometrial stroma, where Smmhc þ SMCs were limited to blood vessels. PDGFRa þ cells were also observed within the myometrium. This labeling was restricted to the interstitial spaces between SMCs (arrowheads). A layer of PDGFRa þ cells was also observed on the serosa (*). Bars in C, F, I, and L represent their respective series of panels.
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PDGF receptor activity, caused a significant decrease in the number of corpora lutea per treated ovary in comparison with the contralateral vehicle-injected control ovary. In addition, some of the treated ovaries displayed widespread hemorrhage throughout the entire ovary, indicating a possible role for PDGF receptor activity in the maintenance of the integrity of the ovarian vasculature [31] .
To determine whether PDGFRa þ cells represented a distinct population of interstitial cell, we performed double-label immunohistochemistry using antibodies against smooth muscle myosin II heavy chain (Smmhc), a specific marker for SMCs [34] and c-Kit, to identify ICCs, which are the pacemaker cells in the oviduct [26, 35] . PDGFRa þ cells did not express considerable Smmhc, supported by a significant fold decrease in Myh11 expression in oviduct and uterus (Table 3) , suggesting they were distinct from SMC in these organs. This finding is not totally conclusive that PDGFRa þ cells do not express Smmhc or that SMCs do not express PDGFRa, just that the protein was below the level of detection using immunohistochemistry. Interestingly, a distinct layer of SMCs was observed to surround follicles, and in some sections there was an apparent thinning of the smooth muscle layer towards 
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þ CELLS IN THE FEMALE REPRODUCTIVE TRACT their outer edges. The role of smooth muscle contraction in ovulation has received little attention; however, it has been suggested that follicular smooth muscle contractions cause the formation of rupture sites and are necessary for ovulation [23, 24] . In the ovary, endothelin-2 (EDN2) is exclusively and transiently expressed in the granulosa cells immediately before ovulation. Administration of EDN2 to ovarian tissues caused rapid contraction of follicular SMC, and treatment with the END2 receptor antagonist tezosentan before ovulation substantially decreased gonadotropin-induced superovulation. From these studies it was concluded that EDN2-induced follicular rupture occurred by constriction of periovulatory follicular smooth muscle [25] . In the oviduct and uterus, PDGFRa þ cells also did not express c-Kit, a marker for pacemaker cells in visceral muscles, and this was also generally supported by fold decreases of gene expression that showed lower levels of Kit in sorted PDGFRa þ cells compared with the total cellular population. In the ovary, it has been shown previously that Kit ligand (stem cell factor) is synthesized by granulosa cells [36, 37] and binds to Kit expressed by oocytes, facilitating the development of the oocyte and stromal cells. Theca cells also express Kit, and their signaling via stem cell factor promotes the formation and proliferation of these cells [38] .
PDGFRa labeling has recently been used to identify a specialized interstitial cell in the GI tracts of rodents [12] [13] [14] [39] [40] [41] , and more recently in humans [42] . These cells, previously known only as ''fibroblast-like'' cells, are closely apposed to enteric motor neurons in the tunica muscularis of the GI tract [12-14, 18, 39-41] . Expression of key receptor and effector proteins raised the possibility that they could be involved in motor neurotransmission, and it was shown that they respond to purine neurotransmitters with robust hyperpolarization responses due to the activation of small conductance calcium-activated potassium channel (SK3) channels and the development of outward current [14] . These cells are now considered a primary target for purinergic inhibitory neurotransmission in the GI tract. An additional population of PDGFRa þ cells exists adjacent to the basolateral surfaces of epithelial cells of the mucosal layers in mouse and humans [42] . The functions of PDGFRa þ cells in the mucosa are not yet determined.
PDGFRa þ cells have also been investigated in mouse, guinea pig, and human bladders. PDGFRa þ cells have been identified in the suburothelium and lamina propria of the bladder mucosa, as well as within detrusor SMCs [15, 17] . These cells were spindle or stellate shaped and formed a loose network. Their close apposition to intramural nerves [15, 17] , as well as their robust expression of the purinergic P2Y1 receptor and SK3 channels [16] , suggested involvement in purinergic neuroeffector responses [43] . Interestingly, some PDGFRa þ cells in the bladder were reported to be vimentin and Kit positive, suggesting possible diversity in this type of interstitial cell in bladder and GI muscles [17] . Although the functional role(s) of PDGFRa þ cells in the female reproductive tract remains unknown, by analogy to other visceral smooth muscle tissues these cells may provide important functions, such as neurotransduction and stabilization of excitability during stretch (filling) of the tissues. For example, if similar ionic conductances and mechanisms are identified in reproductive tract PDGFRa þ cells, it is possible that these cells could be involved in the stabilization of uterine excitability as the fetus grows. The diverse distribution of these cells throughout the reproductive tract suggests many potential roles for these cells in the physiology of reproduction, and it will take some time to investigate their functional roles. We took advantage of the expression of eGFP in the nuclei of Pdgfra þ cells in Pdgfra tm11 (EGFP)Sor /J mice. Isolation of cells by enzymatic dispersion and subsequent purification of cells by FACS allowed cell-specific expression analysis on these unique populations of cells. The initial gene expression studies showed that cells were purified to a large extent, as indicated by a substantial increase in expression of PDGFRa versus levels in unsorted cells. We examined whether these cells have the potential of forming gap junctions with one another to create an electrical syncytium, because of the dense meshlike network of PDGFRa þ cells in the organs of the female reproductive tract. We found enrichment in transcripts for Gja1, which encodes connexin Cx43 in PDGFRa þ cells, except in ovary, suggesting that these cells have the potential for gap junction formation.
PDGFRa þ cells also expressed the early response transcription factor and proto-oncogene Fos. Fos has been shown to participate in a variety of cellular processes, including regulation of cell proliferation, differentiation, apoptosis, and transformation [44] . The deregulation of Fos has been linked to a variety of pathophysiological conditions, including oncogenic transformation [45] . Fos expression or amplification has been shown to occur in ovarian [46] and endometrial [47] carcinomas. Increased PDGFRa expression has been shown to occur in malignant ovarian and uterine 
þ CELLS IN THE FEMALE REPRODUCTIVE TRACT carcinomas, and increased PDGFRa expression is associated with significantly poorer overall survival in patients with these cancers [48] . PDGF signaling has been reported to cause upregulation of Fos [49, 50] . It is possible that mutations in PDGFRa could lead to an increase in Fos expression that might promote cellular oncogenesis, especially in ovarian tissues. In summary, we used a novel mouse model that expresses eGFP in the nuclei of PDGFRa þ cells. We investigated the expression of this new class of interstitial cell in the female reproductive tract and found these cells densely distributed in the muscle and mucosal tissues of ovary, oviduct, and uterus of both mice and monkeys. We used eGFP labeling to isolate and purify PDGFRa þ cells by FACS and performed molecular characterizations of gene expression in cells from different reproductive organs and regions of organs. Differential expression of specific genes in PDGFRa þ cells from different regions suggests diversity of functions between populations of cells. Large-scale determinations of gene expression and fate mapping will be performed in future studies to determine whether these cells change during the reproductive cycle, infections, and pregnancy. We may also be able to learn whether these cells serve as a source of cells that are transformed in malignancies originating in female reproductive organs.
